David A. Siegel Sana Biotechnology, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 19,100 shares of SANA stock, worth $57,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,100Holding current value
$57,490% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding SANA
# of Institutions
169Shares Held
121MCall Options Held
811KPut Options Held
1.29M-
Flagship Pioneering Inc. Cambridge, MA25MShares$75.3 Million16.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$38.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$33.2 Million0.0% of portfolio
-
Baillie Gifford & CO10.3MShares$30.9 Million0.03% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$30.6 Million0.06% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $573M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...